Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesLack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab
International Journal of Hematology, 06/09/09
Ilic I et al. - In a trial to determine the influence of germinal-center B-cell (GCB) and non-GCB phenotypes of diffuse large B-cell lymphoma (DLBCL) on outcome of 92 pts treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP-like chemotherapy, with or without rituximab, it was shown that pts with immunohistochemically determined GCB-type DLBCL did not have an improved prognosis, irrespective of whether they had received rituximab or not.
Methods- The differentiation between GCB and non-GCB types was arrived at by immunohistochemistry using previously published criteria.
- 39 pts had the GCB and 53 had the non-GCB type of DLBCL.
- 49 pts were treated with rituximab and chemotherapy; 43 were treated with chemotherapy alone.
- The GCB and non-GCB group did not differ in their international prognostic index factors and score, presence of bulky disease, or frequency of rituximab treatment.
- Median follow-up of surviving pts was carried out for 37 mos.
- There was no difference between GCB and non-GCB groups in both overall response rates (67 vs 70%, respectively) and estimated rates of 3-yr event-free (46 vs 49%, respectively) and overall (54 vs 56%, respectively) survival.
- No differences of the outcomes were observed between subgroups treated with or without rituximab.
Related Articles
Preoperative Erythrocyte Sedimentation Rate Is an Independent Prognostic Factor in Japanese Patients with Localized Clear Cell Renal Cell Carcinoma
Urologia Internationalis, 10/21/09
Relevance Score: 67%
Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: Effects of rituximab
Annals of Oncology, 11/10/09
Relevance Score: 66%
Prognostic value of quantitative p63 immunostaining in adenoid cystic carcinoma of salivary gland assessed by computerized image analysis
Cancer, 11/04/09
Relevance Score: 66%
Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma
Cancer, 10/26/09
Relevance Score: 66%
The Correlation and Prognostic Significance of Mgmt Promoter Methylation and Mgmt Protein in Glioblastomas
Neurosurgery, 10/22/09
Relevance Score: 66%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 2010
Cell Therapeutics, 12/18/09
Oral Chemotherapy in Hormone-Refractory Prostate Carcinoma Patients Unwilling to Be Admitted to Hospital
Urologia Internationalis, 12/18/09
Taurolidine in the prevention and therapy of lung metastases
European Journal of Cardio-Thoracic Surgery, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor